Hence, future research should address and elucidate the signaling pathways by which FFARs mediate the effects of fatty acids on insulin secretion and lipotoxicity, which could lead to new therapeutic strategies for managing insulin resistance and related metabolic disorders. The gene discussed is INS; the disease is metabolic disease.